The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia [2]

Journal of Clinical Psychiatry

Volumn 61, Issue 12, 2000, Pages 948-

  Martin J C ^a   Palenciano, G ^a   Perez R ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LITHIUM CARBONATE; OLANZAPINE; THIORIDAZINE;

ADULT; ANXIETY; BEHAVIOR; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; FOLLOW UP; HOSPITALIZATION; HUMAN; LETTER; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034531008     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n1210b     Document Type: Letter

References (9)

1. Expert Consensus Guideline Series: Treatment of Schizophrenia
2. Lithium augmentation fails to reduce symptoms m poorly responsive schizophrenic outpatients
3. When the symptoms persist: Choosing among alternative somatic treatments for schizophrenia
4. Olanzapine versus placebo and haloperidol: Acute phase results of the North American doubleblind olanzapine trial
5. Olanzapine in treatment-refractory schizophrema: Results of an open-label study
6. Treatment failure with clozapine: Can olanzapine be the alternative therapy?
7. Olanzapine compared with chlorpromazine in treatment-resistant schizophrema
8. Interaction between olanzapine and lithium in healthy male volunteers